1 Doxorubicin Injection Market Overview 1.1 Product Overview and Scope of Doxorubicin Injection 1.2 Doxorubicin Injection Segment by Type 1.2.1 Global Doxorubicin Injection Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 5ml/vial 1.2.3 10ml/vial 1.2.4 50ml/vial 1.3 Doxorubicin Injection Segment by Application 1.3.1 Global Doxorubicin Injection Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Recovery Center 1.4 Global Doxorubicin Injection Market Size Estimates and Forecasts 1.4.1 Global Doxorubicin Injection Revenue 2017-2028 1.4.2 Global Doxorubicin Injection Sales 2017-2028 1.4.3 Doxorubicin Injection Market Size by Region: 2017 Versus 2021 Versus 2028 2 Doxorubicin Injection Market Competition by Manufacturers 2.1 Global Doxorubicin Injection Sales Market Share by Manufacturers (2017-2022) 2.2 Global Doxorubicin Injection Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Doxorubicin Injection Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Doxorubicin Injection Manufacturing Sites, Area Served, Product Type 2.5 Doxorubicin Injection Market Competitive Situation and Trends 2.5.1 Doxorubicin Injection Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Doxorubicin Injection Players Market Share by Revenue 2.5.3 Global Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Doxorubicin Injection Retrospective Market Scenario by Region 3.1 Global Doxorubicin Injection Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Doxorubicin Injection Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Doxorubicin Injection Market Facts & Figures by Country 3.3.1 North America Doxorubicin Injection Sales by Country 3.3.2 North America Doxorubicin Injection Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Doxorubicin Injection Market Facts & Figures by Country 3.4.1 Europe Doxorubicin Injection Sales by Country 3.4.2 Europe Doxorubicin Injection Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Doxorubicin Injection Market Facts & Figures by Region 3.5.1 Asia Pacific Doxorubicin Injection Sales by Region 3.5.2 Asia Pacific Doxorubicin Injection Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Doxorubicin Injection Market Facts & Figures by Country 3.6.1 Latin America Doxorubicin Injection Sales by Country 3.6.2 Latin America Doxorubicin Injection Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Doxorubicin Injection Market Facts & Figures by Country 3.7.1 Middle East and Africa Doxorubicin Injection Sales by Country 3.7.2 Middle East and Africa Doxorubicin Injection Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Doxorubicin Injection Historic Market Analysis by Type 4.1 Global Doxorubicin Injection Sales Market Share by Type (2017-2022) 4.2 Global Doxorubicin Injection Revenue Market Share by Type (2017-2022) 4.3 Global Doxorubicin Injection Price by Type (2017-2022) 5 Global Doxorubicin Injection Historic Market Analysis by Application 5.1 Global Doxorubicin Injection Sales Market Share by Application (2017-2022) 5.2 Global Doxorubicin Injection Revenue Market Share by Application (2017-2022) 5.3 Global Doxorubicin Injection Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Hikma 6.1.1 Hikma Corporation Information 6.1.2 Hikma Description and Business Overview 6.1.3 Hikma Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Hikma Doxorubicin Injection Product Portfolio 6.1.5 Hikma Recent Developments/Updates 6.2 Athenex 6.2.1 Athenex Corporation Information 6.2.2 Athenex Description and Business Overview 6.2.3 Athenex Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Athenex Doxorubicin Injection Product Portfolio 6.2.5 Athenex Recent Developments/Updates 6.3 Fresenius Kabi 6.3.1 Fresenius Kabi Corporation Information 6.3.2 Fresenius Kabi Description and Business Overview 6.3.3 Fresenius Kabi Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Fresenius Kabi Doxorubicin Injection Product Portfolio 6.3.5 Fresenius Kabi Recent Developments/Updates 6.4 Mylan 6.4.1 Mylan Corporation Information 6.4.2 Mylan Description and Business Overview 6.4.3 Mylan Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Mylan Doxorubicin Injection Product Portfolio 6.4.5 Mylan Recent Developments/Updates 6.5 Sagent 6.5.1 Sagent Corporation Information 6.5.2 Sagent Description and Business Overview 6.5.3 Sagent Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Sagent Doxorubicin Injection Product Portfolio 6.5.5 Sagent Recent Developments/Updates 6.6 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description and Business Overview 6.6.3 Teva Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Teva Doxorubicin Injection Product Portfolio 6.6.5 Teva Recent Developments/Updates 6.7 Caraco 6.6.1 Caraco Corporation Information 6.6.2 Caraco Description and Business Overview 6.6.3 Caraco Doxorubicin Injection Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Caraco Doxorubicin Injection Product Portfolio 6.7.5 Caraco Recent Developments/Updates 7 Doxorubicin Injection Manufacturing Cost Analysis 7.1 Doxorubicin Injection Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Doxorubicin Injection 7.4 Doxorubicin Injection Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Doxorubicin Injection Distributors List 8.3 Doxorubicin Injection Customers 9 Doxorubicin Injection Market Dynamics 9.1 Doxorubicin Injection Industry Trends 9.2 Doxorubicin Injection Market Drivers 9.3 Doxorubicin Injection Market Challenges 9.4 Doxorubicin Injection Market Restraints 10 Global Market Forecast 10.1 Doxorubicin Injection Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Doxorubicin Injection by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Doxorubicin Injection by Type (2023-2028) 10.2 Doxorubicin Injection Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Doxorubicin Injection by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Doxorubicin Injection by Application (2023-2028) 10.3 Doxorubicin Injection Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Doxorubicin Injection by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Doxorubicin Injection by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Doxorubicin Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Doxorubicin Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Doxorubicin Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Doxorubicin Injection Market Competitive Situation by Manufacturers in 2021 Table 5. Global Doxorubicin Injection Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Doxorubicin Injection Sales Market Share by Manufacturers (2017-2022) Table 7. Global Doxorubicin Injection Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Doxorubicin Injection Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Doxorubicin Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Doxorubicin Injection Manufacturing Sites and Area Served Table 11. Manufacturers Doxorubicin Injection Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Doxorubicin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxorubicin Injection as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Doxorubicin Injection Sales by Region (2017-2022) & (K Units) Table 16. Global Doxorubicin Injection Sales Market Share by Region (2017-2022) Table 17. Global Doxorubicin Injection Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Doxorubicin Injection Revenue Market Share by Region (2017-2022) Table 19. North America Doxorubicin Injection Sales by Country (2017-2022) & (K Units) Table 20. North America Doxorubicin Injection Sales Market Share by Country (2017-2022) Table 21. North America Doxorubicin Injection Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Doxorubicin Injection Revenue Market Share by Country (2017-2022) Table 23. Europe Doxorubicin Injection Sales by Country (2017-2022) & (K Units) Table 24. Europe Doxorubicin Injection Sales Market Share by Country (2017-2022) Table 25. Europe Doxorubicin Injection Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Doxorubicin Injection Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Doxorubicin Injection Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Doxorubicin Injection Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Doxorubicin Injection Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Doxorubicin Injection Revenue Market Share by Region (2017-2022) Table 31. Latin America Doxorubicin Injection Sales by Country (2017-2022) & (K Units) Table 32. Latin America Doxorubicin Injection Sales Market Share by Country (2017-2022) Table 33. Latin America Doxorubicin Injection Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Doxorubicin Injection Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Doxorubicin Injection Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Doxorubicin Injection Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Doxorubicin Injection Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Doxorubicin Injection Revenue Market Share by Country (2017-2022) Table 39. Global Doxorubicin Injection Sales by Type (2017-2022) & (K Units) Table 40. Global Doxorubicin Injection Sales Market Share by Type (2017-2022) Table 41. Global Doxorubicin Injection Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Doxorubicin Injection Revenue Share by Type (2017-2022) Table 43. Global Doxorubicin Injection Price by Type (2017-2022) & (US$/Unit) Table 44. Global Doxorubicin Injection Sales (K Units) by Application (2017-2022) Table 45. Global Doxorubicin Injection Sales Market Share by Application (2017-2022) Table 46. Global Doxorubicin Injection Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Doxorubicin Injection Revenue Share by Application (2017-2022) Table 48. Global Doxorubicin Injection Price by Application (2017-2022) & (US$/Unit) Table 49. Hikma Corporation Information Table 50. Hikma Description and Business Overview Table 51. Hikma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Hikma Doxorubicin Injection Product Table 53. Hikma Recent Developments/Updates Table 54. Athenex Corporation Information Table 55. Athenex Description and Business Overview Table 56. Athenex Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Athenex Doxorubicin Injection Product Table 58. Athenex Recent Developments/Updates Table 59. Fresenius Kabi Corporation Information Table 60. Fresenius Kabi Description and Business Overview Table 61. Fresenius Kabi Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Fresenius Kabi Doxorubicin Injection Product Table 63. Fresenius Kabi Recent Developments/Updates Table 64. Mylan Corporation Information Table 65. Mylan Description and Business Overview Table 66. Mylan Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Mylan Doxorubicin Injection Product Table 68. Mylan Recent Developments/Updates Table 69. Sagent Corporation Information Table 70. Sagent Description and Business Overview Table 71. Sagent Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Sagent Doxorubicin Injection Product Table 73. Sagent Recent Developments/Updates Table 74. Teva Corporation Information Table 75. Teva Description and Business Overview Table 76. Teva Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Teva Doxorubicin Injection Product Table 78. Teva Recent Developments/Updates Table 79. Caraco Corporation Information Table 80. Caraco Description and Business Overview Table 81. Caraco Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Caraco Doxorubicin Injection Product Table 83. Caraco Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Doxorubicin Injection Distributors List Table 87. Doxorubicin Injection Customers List Table 88. Doxorubicin Injection Market Trends Table 89. Doxorubicin Injection Market Drivers Table 90. Doxorubicin Injection Market Challenges Table 91. Doxorubicin Injection Market Restraints Table 92. Global Doxorubicin Injection Sales Forecast by Type (2023-2028) & (K Units) Table 93. Global Doxorubicin Injection Sales Market Share Forecast by Type (2023-2028) Table 94. Global Doxorubicin Injection Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Doxorubicin Injection Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Doxorubicin Injection Sales Forecast by Application (2023-2028) & (K Units) Table 97. Global Doxorubicin Injection Sales Market Share Forecast by Application (2023-2028) Table 98. Global Doxorubicin Injection Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Doxorubicin Injection Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Doxorubicin Injection Sales Forecast by Region (2023-2028) & (K Units) Table 101. Global Doxorubicin Injection Sales Market Share Forecast by Region (2023-2028) Table 102. Global Doxorubicin Injection Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Doxorubicin Injection Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Doxorubicin Injection Figure 2. Global Doxorubicin Injection Market Share by Type in 2021 & 2028 Figure 3. 5ml/vial Product Picture Figure 4. 10ml/vial Product Picture Figure 5. 50ml/vial Product Picture Figure 6. Global Doxorubicin Injection Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Clinics Figure 9. Recovery Center Figure 10. Global Doxorubicin Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Doxorubicin Injection Market Size (2017-2028) & (US$ Million) Figure 12. Global Doxorubicin Injection Sales (2017-2028) & (K Units) Figure 13. Doxorubicin Injection Sales Share by Manufacturers in 2021 Figure 14. Global Doxorubicin Injection Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Doxorubicin Injection Players: Market Share by Revenue in 2021 Figure 16. Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Doxorubicin Injection Sales Market Share by Region (2017-2022) Figure 18. Global Doxorubicin Injection Sales Market Share by Region in 2021 Figure 19. Global Doxorubicin Injection Revenue Market Share by Region (2017-2022) Figure 20. Global Doxorubicin Injection Revenue Market Share by Region in 2021 Figure 21. U.S. Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Doxorubicin Injection Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Doxorubicin Injection by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Doxorubicin Injection Figure 47. Manufacturing Process Analysis of Doxorubicin Injection Figure 48. Doxorubicin Injection Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Hikma Athenex Fresenius Kabi Mylan Sagent Teva Caraco